Clinical pharmacy in geriatrics and 20 years of clinical and scientific experience with the evaluation of rationality of geriatric drug prescribing in the Czech republic and European countries
Abstract
Publication summarizes activities realized in the past 20 years (2000-2020) in the development of clinical pharmacy in geriatrics in clinical and scientific areas. In clinical area it emphasizes specific features of rational geriatric pharmacotherapy in comparison to classical internal medicine and specific aspects of evaluation and individualization of drug schemes in older patients.
It highlights important role of clinical pharmacists as specialists in the field of clinical pharmacy in individualization of drug schemes and reguirements of deep knowledge of clinical pharmacy in geriatrics, risk-management, applied geriatric pharmacology, current geriatric studies and principles of individualized geriatric pharmacotherapy. In the scientific area it summarizes significant research activities in the Czech Republic and Europe that contributed to the development of clinical pharmacy in geriatrics and in which the scientific group PROGRESS Q42 KSKF-2 of the Faculty of Pharmacy, Charles University was involved, entitled "Aging, Polypharmacy and Changes in the Therapeutic Value of Drugs in the AgeD" (chair: Assoc. prof.
Fialová). From these scientific activities are stated in this publication mainly analyses of rational geriatric pharmacotherapy in European projects ADHOC (AgeD in HOme Care, 5th Framework Program of the European Commission, 2001-2005), SHELTER (Services and Health in the Elderly in Long-term Care, 7th Framework program of the European Comission, 2009-2014), EU COST Action IS1402 project "Ageism-interdisciplinary, multiprofessional perspectives" (2015-2018), currently ongoing project EUROAGEISM Horizon 2020-MCSF-INT-764632 (2017-2021) and newly submitted EU project "I-CARE4OLD" in the Horizon 2020 program.